- Published on
Diagnostic Test – Bone Scan (Technetium Pyrophosphate Nuclear Bone Scan)
1. What is this?
A nuclear bone scan using technetium-labeled pyrophosphate is an imaging study used to detect occult disease involving bone.
It is particularly helpful when pathology is not visible on plain radiographs.
2. How does it work?
- Technetium is taken up by osteoblasts
- It is deposited in areas of new bone matrix formation
- Regions with increased osteoblastic activity demonstrate increased radiotracer uptake (“hot spots”)
- Osteoblastic activity is required for a lesion to be detected on bone scan
3. What makes it abnormal?
A bone scan becomes abnormal when there is increased uptake due to:
- Infection
- Osteomyelitis
- Malignancy
- Primary bone tumors or metastatic disease
- Bone scans are highly sensitive but poorly specific
- They often cannot differentiate bone involvement from adjacent soft-tissue infection
4. What is the most accurate test?
- A bone biopsy is the definitive diagnostic test
- It is required to determine the exact etiology of an abnormal bone scan
- Culture for infection
- Histology for malignancy
- Published on
Diagnostic Test – Bone Biopsy
1. When is bone biopsy the appropriate choice?
Select bone biopsy when the clinical scenario suggests osteomyelitis and definitive diagnosis is required, especially in:
2. For which diseases is this the gold-standard diagnostic test?
A needle aspirate bone biopsy examined microscopically is the gold-standard diagnostic test for:
It allows for histologic evaluation and microbiologic culture.
3. What tests can replace this biopsy if osteomyelitis is suspected?
A bone biopsy may be avoided when both of the following are present:
In this setting, the diagnosis of osteomyelitis can be established without biopsy.
1. When is bone biopsy the appropriate choice?
Select bone biopsy when the clinical scenario suggests osteomyelitis and definitive diagnosis is required, especially in:
- Patients with diabetes mellitus and peripheral vascular disease
- Chronic leg or foot pain with:
- Warmth
- Ulceration
- Imaging abnormalities on X-ray or MRI consistent with bone infection
2. For which diseases is this the gold-standard diagnostic test?
A needle aspirate bone biopsy examined microscopically is the gold-standard diagnostic test for:
- Osteomyelitis
- Primary bone tumors
- Metastatic bone (osseous) disease
It allows for histologic evaluation and microbiologic culture.
3. What tests can replace this biopsy if osteomyelitis is suspected?
A bone biopsy may be avoided when both of the following are present:
- Radiographic evidence of osteomyelitis (X-ray or MRI findings)
- Positive blood cultures identifying a causative organism
In this setting, the diagnosis of osteomyelitis can be established without biopsy.
- Published on
Diagnostic Tests – VDRL and RPR (Nontreponemal Tests)
1. For which disease(s) are these tests used?
VDRL (Venereal Disease Research Laboratory) and RPR (Rapid Plasma Reagin) are nontreponemal serologic tests used for the screening and diagnosis of syphilis. They detect antibodies directed against cardiolipin released from damaged host cells and treponemes.
2. What signs and symptoms would you expect?
Clinical features vary by stage:
If clinical suspicion remains high:
5. What is the response to treatment?
High-yield exam pearls
1. For which disease(s) are these tests used?
VDRL (Venereal Disease Research Laboratory) and RPR (Rapid Plasma Reagin) are nontreponemal serologic tests used for the screening and diagnosis of syphilis. They detect antibodies directed against cardiolipin released from damaged host cells and treponemes.
2. What signs and symptoms would you expect?
Clinical features vary by stage:
- Primary syphilis
- Painless chancre
- Painless regional lymphadenopathy
- Secondary syphilis
- Diffuse rash (often involving palms and soles)
- Generalized lymphadenopathy
- Condylomata lata
- Patchy alopecia
- Tertiary syphilis
- Cardiac disease (e.g., aortitis)
- Neurologic disease (neurosyphilis)
- Gummatous lesions
- False positives may occur with:
- Connective tissue diseases
- Infectious mononucleosis
- Malaria
- Leprosy
- IV drug use
- Hepatitis C
- Infective endocarditis
- Pregnancy
- False negatives:
- Prozone phenomenon, caused by very high antibody titers that interfere with test reactivity
If clinical suspicion remains high:
- Primary syphilis → Darkfield microscopy of the chancre
- Other stages → FTA-ABS (Fluorescent Treponemal Antibody–Absorption test)
5. What is the response to treatment?
- VDRL and RPR titers decrease or become negative with successful treatment → useful for monitoring response
- FTA-ABS may remain positive for life, even after adequate therapy
High-yield exam pearls
- Screening & monitoring → VDRL / RPR
- Confirmation → FTA-ABS
- Early primary lesion → Darkfield examination
- Published on
Diagnostic Test – CD4 (T-Cell) Counts
1. What is this?
The CD4 (T-cell) count is a laboratory test used to monitor patients with HIV infection.
It measures the number of CD4⁺ helper T lymphocytes in the blood, which reflects the degree of immune function.
Clinical roles of the CD4 count:
Treatment threshold (classic exam standard):
1. What is this?
The CD4 (T-cell) count is a laboratory test used to monitor patients with HIV infection.
It measures the number of CD4⁺ helper T lymphocytes in the blood, which reflects the degree of immune function.
Clinical roles of the CD4 count:
- Assess severity of immunosuppression
- Determine the need for opportunistic infection prophylaxis
- Monitor response to antiretroviral therapy (ART)
Treatment threshold (classic exam standard):
- Initiate antiretroviral therapy when:
- CD4
- Published on
Diagnostic Tests – Antihistone Antibodies
1. What are they specific for?
Antihistone antibodies are most strongly associated with drug-induced lupus erythematosus (DILE). They are commonly positive in patients who develop lupus-like symptoms after exposure to certain medications.
High-risk medications include:
Lupus symptoms + chronic drug exposure → antihistone antibodies
2. What is the treatment?
There is no specific immunologic therapy required.
✅ Stop the offending medication
Symptoms usually resolve after drug discontinuation, and long-term organ damage is uncommon compared with idiopathic SLE.
Key distinction
1. What are they specific for?
Antihistone antibodies are most strongly associated with drug-induced lupus erythematosus (DILE). They are commonly positive in patients who develop lupus-like symptoms after exposure to certain medications.
High-risk medications include:
- Procainamide
- Hydralazine
- Phenytoin
- Sulfonamides
- Isoniazid
- Penicillamine
Lupus symptoms + chronic drug exposure → antihistone antibodies
2. What is the treatment?
There is no specific immunologic therapy required.
✅ Stop the offending medication
Symptoms usually resolve after drug discontinuation, and long-term organ damage is uncommon compared with idiopathic SLE.
Key distinction
- Drug-induced lupus → Antihistone antibodies
- Idiopathic SLE → Anti-dsDNA / Anti-Sm antibodies
- Published on
Diagnostic Tests – Polymerase Chain Reaction (PCR) HIV RNA Viral Load
1. What is this?
The PCR HIV RNA viral load test is a quantitative blood test that measures the amount of HIV RNA circulating in the bloodstream. It directly reflects the level of viral replication and is one of the most important tools for monitoring HIV infection.
2. When this test is mentioned, what should you think of?
When you see PCR HIV RNA viral load, think disease activity and treatment response:
• It is the first parameter to change after starting effective antiretroviral therapy (ART)
• It is also the earliest indicator of treatment failure or nonadherence
• Viral load predicts the rate of CD4 (T-helper cell) decline
• High viral load → rapid disease progression
• Low or undetectable viral load → slower progression and effective therapy
Exam pearl:
Viral load changes before CD4 count does.
3. When do you answer PCR HIV RNA viral load?
You should select PCR HIV RNA viral load testing in the following situations:
• At the time of initial HIV diagnosis
• Every 3–4 months to monitor response to therapy
• When treatment failure is suspected
• When performing HIV resistance (sensitivity) testing, as viral load measurement is required to assess resistance in a failing regimen
High-yield summary
• Best test for monitoring treatment response → PCR HIV RNA viral load
• Best predictor of disease progression → PCR HIV RNA viral load
• Diagnosis of HIV → antibody/antigen testing (not viral load)
1. What is this?
The PCR HIV RNA viral load test is a quantitative blood test that measures the amount of HIV RNA circulating in the bloodstream. It directly reflects the level of viral replication and is one of the most important tools for monitoring HIV infection.
2. When this test is mentioned, what should you think of?
When you see PCR HIV RNA viral load, think disease activity and treatment response:
• It is the first parameter to change after starting effective antiretroviral therapy (ART)
• It is also the earliest indicator of treatment failure or nonadherence
• Viral load predicts the rate of CD4 (T-helper cell) decline
• High viral load → rapid disease progression
• Low or undetectable viral load → slower progression and effective therapy
Exam pearl:
Viral load changes before CD4 count does.
3. When do you answer PCR HIV RNA viral load?
You should select PCR HIV RNA viral load testing in the following situations:
• At the time of initial HIV diagnosis
• Every 3–4 months to monitor response to therapy
• When treatment failure is suspected
• When performing HIV resistance (sensitivity) testing, as viral load measurement is required to assess resistance in a failing regimen
High-yield summary
• Best test for monitoring treatment response → PCR HIV RNA viral load
• Best predictor of disease progression → PCR HIV RNA viral load
• Diagnosis of HIV → antibody/antigen testing (not viral load)
- Published on
Diagnostic Tests – India Ink Stain (Cryptococcal Meningitis)
1. What is this?
An India ink stain is a microscopic examination of cerebrospinal fluid (CSF) used to detect Cryptococcus neoformans.
This organism has a thick mucopolysaccharide capsule that repels the ink, creating a characteristic clear halo surrounding the yeast against a dark background.
2. When is this the answer
You should choose India ink staining as the best initial diagnostic test when the clinical scenario describes:
CSF findings often show:
AIDS + subacute meningitis → India ink stain
3. What is the most accurate diagnostic test?
The most accurate tests for cryptococcal meningitis are:
These tests are more sensitive than India ink staining and are used to confirm the diagnosis.
Key comparison
1. What is this?
An India ink stain is a microscopic examination of cerebrospinal fluid (CSF) used to detect Cryptococcus neoformans.
This organism has a thick mucopolysaccharide capsule that repels the ink, creating a characteristic clear halo surrounding the yeast against a dark background.
2. When is this the answer
You should choose India ink staining as the best initial diagnostic test when the clinical scenario describes:
- A patient with advanced AIDS (typically CD4 <100 cells />micro;L)
- Fever and headache
- Possible neck stiffness
- A subacute presentation (slower onset and less severe than bacterial meningitis)
CSF findings often show:
- Mild lymphocytic pleocytosis
- CSF protein and white blood cell counts may be normal, which does not exclude cryptococcal meningiti
AIDS + subacute meningitis → India ink stain
3. What is the most accurate diagnostic test?
The most accurate tests for cryptococcal meningitis are:
- Cryptococcal antigen testing (CSF or serum)
- Fungal culture of the CSF
These tests are more sensitive than India ink staining and are used to confirm the diagnosis.
Key comparison
- Best initial test (classic boards) → India ink stain
- Most accurate test → Cryptococcal antigen or fungal culture
- Published on
Diagnostic Tests – Muscle Biopsy
1. For which clinical condition(s) would you use this test?
A muscle biopsy is used to diagnose primary myopathies, particularly when a structural, metabolic, inflammatory, or genetic muscle disorder is suspected. Conditions commonly diagnosed with muscle biopsy include:
2. When do you answer muscle biopsy?
You should choose muscle biopsy when the clinical scenario describes:
Proximal weakness + myalgias + suspected intrinsic muscle disease → Muscle biopsy
3. For which muscle diseases would you
not
answer muscle biopsy?
Despite overlapping symptoms of weakness, muscle biopsy is NOT the correct test in the following situations:
1. For which clinical condition(s) would you use this test?
A muscle biopsy is used to diagnose primary myopathies, particularly when a structural, metabolic, inflammatory, or genetic muscle disorder is suspected. Conditions commonly diagnosed with muscle biopsy include:
- Glycogen storage diseases
- Mitochondrial myopathies
- Dystrophinopathies (e.g., Duchenne and Becker muscular dystrophy)
- Inflammatory myopathies, such as dermatomyositis and polymyositis
2. When do you answer muscle biopsy?
You should choose muscle biopsy when the clinical scenario describes:
- Proximal muscle weakness, such as:
- Difficulty with shoulder abduction
- Trouble rising from a chair
- Associated myalgias (muscle soreness)
- Evidence of myopathy, such as:
- Elevated muscle enzymes
- Recurrent rhabdomyolysis
- A possible family history of similar symptoms, suggesting an inherited muscle disorder
Proximal weakness + myalgias + suspected intrinsic muscle disease → Muscle biopsy
3. For which muscle diseases would you
not
answer muscle biopsy?
Despite overlapping symptoms of weakness, muscle biopsy is NOT the correct test in the following situations:
- Endocrine-related myopathies
- Examples: thyroid disease, diabetes
- Appropriate tests: specific endocrine laboratory testing
- Neuromuscular junction disorders
- Example: myasthenia gravis
- Appropriate tests:
- Edrophonium (Tensilon) testing
- Anti–acetylcholine receptor antibodies
- Electromyography (EMG)
- Muscle fiber disease → muscle biopsy
- Endocrine or neuromuscular junction disease → targeted labs or electrophysiologic testing
- Published on
Diagnostic Tests – DEXA Scanning (Dual-Energy X-ray Absorptiometry)
1. What does it show?
A DEXA scan measures bone mineral density (BMD) and is the standard test used to diagnose osteoporosis. It compares a patient’s bone density to that of a healthy young adult population and reports results as T-scores, allowing assessment of fracture risk and bone loss severity.
2. When do you answer a DEXA scan?
You should select DEXA scanning when evaluating patients at high risk for osteoporosis, including:
Exam pearl:
Any condition causing increased bone resorption or decreased bone formation → think DEXA scan.
3. What is the treatment?
Management of osteoporosis includes:
1. What does it show?
A DEXA scan measures bone mineral density (BMD) and is the standard test used to diagnose osteoporosis. It compares a patient’s bone density to that of a healthy young adult population and reports results as T-scores, allowing assessment of fracture risk and bone loss severity.
2. When do you answer a DEXA scan?
You should select DEXA scanning when evaluating patients at high risk for osteoporosis, including:
- Postmenopausal women
- Patients with high cortisol states, such as:
- Cushing’s syndrome
- Chronic exogenous steroid use
- Patients with hyperthyroidism
- Patients with hyperparathyroidism
Exam pearl:
Any condition causing increased bone resorption or decreased bone formation → think DEXA scan.
3. What is the treatment?
Management of osteoporosis includes:
- Estrogen therapy (selected postmenopausal patients)
- Bisphosphonates (first-line therapy for most patients)
- Selective estrogen receptor modulators (SERMs) such as:
- Raloxifene
- TamoxifeN
- Published on
Diagnostic Tests-ANA, Anti–Double-Stranded DNA (anti-dsDNA), and Anti-Smith (anti-Sm) Antibodies
1.
What diseases are they associated with?
- ANA (Antinuclear Antibody)
- More than 98% sensitive for systemic lupus erythematosus (SLE)
- Not specific for SLE (can be positive in other autoimmune diseases and even in healthy individuals)
- A negative ANA essentially excludes SLE, with about a 98% negative predictive value
- Anti–double-stranded DNA (anti-dsDNA)
- Approximately 99% specific for SLE
- Levels often correlate with disease activity, particularly lupus nephritis
- Anti-Smith (anti-Sm)
- Extremely specific for SLE
- Less sensitive, but when present, it is diagnostic of lupus
2.
When do you answer/order this test?
Answer ANA, anti-dsDNA, and anti-Sm antibodies when the clinical presentation suggests systemic lupus erythematosus, classically:
- Young female with:
- Multiple spontaneous abortions (suggesting lupus anticoagulant / antiphospholipid antibodies)
- Rash (malar or photosensitive)
- Joint pains / inflammatory arthritis
- May also have renal disease, cytopenias, or serositis
- ANA → screening test (rules out SLE if negative)
- Anti-dsDNA & Anti-Sm → confirmatory tests (rule in SLE if positive)
